Molecular Pathogenic Mechanisms of IgA Nephropathy Secondary to COVID-19 mRNA Vaccination
Introduction: Accumulating evidence has disclosed that IgA nephropathy (IgAN) could present shortly after the second dose of COVID-19 mRNA vaccine. However, the undying mechanism remains unclear and we aimed to investigate the potential molecular mechanisms. Methods: We downloaded gene expression da...
Main Authors: | Luoyi Wang, Zhaomin Mao, Lirong Zhang, Fengmin Shao |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2024-02-01
|
Series: | Kidney & Blood Pressure Research |
Subjects: | |
Online Access: | https://beta.karger.com/Article/FullText/535626 |
Similar Items
-
Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy
by: Kai Zhang, et al.
Published: (2019-10-01) -
Glomerular Galactose-Deficient IgA1(KM55) Positive May Predict Poorer Prognosis in Coexisting Primary Membranous Nephropathy and IgA Nephropathy Patients
by: Wenrong Cheng, et al.
Published: (2022-12-01) -
Urinary sediment mRNA as a potent biomarker of IgA nephropathy
by: Jin Sug Kim, et al.
Published: (2024-11-01) -
Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
by: Yoshihito Nihei, et al.
Published: (2023-04-01) -
Oxford classification of IgA nephropathy: Broadening the scope of the classification
by: Muhammed Mubarak
Published: (2012-04-01)